Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

124 model monitoring

12th World AIDS Conference

ents - Based on in vitro
evelopment of self-care
ansmission: IHO-Wadia
on?/Could the REACH
IDS: A suggestion for a
a group empowerment
herence: A patient-team
Test of a coping support
ort/The Soweto HOPE
munity based integrated
e hu-PBL-SCID mouse
sing population/A care
and drug resistance: A
ctivity of microbicides in
Macaques as an animal
or injection drug use: A
Well womans clinic - A
gramme/Cost-effective
azilian women/A belief
ventive and therapeutic
/BAR&ONG project: A
ort/The Soweto HOPE
fective service delivery
a/Partners in caring: A
ricans/A psycho-social
ent and client follow-up
IV/AIDS in Romania/A
-/: Efficiency in the SIV
ills: A training program
eening using an in vitro
ry systems/Innovative
st (PCS): An alternative
/AIDS ambulatory care
of a Freirian education
vation-behavioral skills
Canadian experience/A
finition/A change-point
nd Wales/A simulation
al networks of youth to
gression: A population
ugh a back-calculation
ect becomes replicable
tion and Mover-Stayer
obi: Evaluation with the
tion in the workplace/A
itiative: A collaborative
ramming: An emerging
/Evaluation of a unique
prehensive community
oluntary HIV testing and
n subjects protection/A
d by HIV/Mathematical
erence: An educational
s family-based support
nts entering innovative
ruction of the Brazilian
of the AVERT computer
nfection/An alternative
CES: An empowerment
world/The health belief
nctuary compartment/
avenous drug injectors/
apy for HIV-1 infection:
o treatment changes/
n antiretroviral therapy/
HIV infected patients: A
ment using a simulation
e combination therapy/
ew of HIV clinical trials/

SKeyword Abstr
/Ritonavir-containing dual protease
for persons with HIV/AIDS/Develop
/Prevention of perinatal transmissio
be the panacea to female genital cu
/The coming out process among ga
for HIV+ gay Puerto Rican men/Ev
/Ensuring adherence: A patient-tea
/Work-related stress and occupatio
for community based support/The
/Psychological support for HIV posit
/Study of the impact of neutralizing
for HIV-infected pregnant women (
for cross-cultural treatment educati
systems/Anti-viral activity of microb
to evaluate vaginal microbicide/Ge
feasibility program/Post-exposure
clinic for diagnosis, care and health
for developing a blood donor couns
of sexual behavior of HIV-1 seropos
about the HIV/AIDS problematical/
for poor under served communities i
for peer education and support/The
/Creation of HIV/AIDS drop-in cente
for supportive care for rural America
for services to African-Americans/
to link HIV and primary health and s
of care for children and families affe
/AIDS gene therapy based on antivi
for health and support workers work
of the blood-cerebrospinal fluid (CS
for the provision of HIV primary care
of care for patients with HIV/HIV ph
for optimal patient care in Bangkok,
to train Latin American immigrants t
to HIV prevention/Contributions of t
for corrections and community healt
for reporting delays under change o
to investigate the 1996-97 decline i
the social and geographic spread of
for Scotland/The effect of combinat
/The modification of the AIDS incub
and leads to plateauing in Mumbai/
to estimate the size of the HIV/AIDS
STDSIM/The impact of partner refe
programme on HIV prevention in th
for catalyzing and coordinating a co
of practice/Integrating communityof respite care: Victoria AIDS Respit
/Developing HIV programs within i
counselling centre - A pilot project/
for improved human subjects prote
to estimate the probability of being i
for non-medical HIV service provide
/Who invited HIV/AIDS? 1st nations
programs to improve medication ad
of harm reduction: From the health
/Estimating program impact on HIV
for support groups for health care w
for Latinos in Maryland, USA/LUCE
and the theory of reasoned action:
Modeling the sources for persistent HIV lo
HIV transmission risk in non-intr
when to change therapy/Manag
the dynamics in plasma viral loa
the potential economic impact of
modeling approach/Effect of multitherapi
approach/Cost effectiveness of
Modelling disease progression in HIV-infe
Models of practice for ethical review of HIV

act
22350
22447
23309
23384
24110
24276
24286
24300
24349
24354
330*/31103
32228
32363
33149
33156
249*/33172
33255
33271
33320
33425
33430
33573
34123
34193
34204
34209
34339
41248
42233
42270
42312
42410
42447
43185
43319
43404
43443
43469
43470
43471
43480
43483
43487
43490
43507
44222
44293
44304
60002
60139
60174
60197
60362
60376
60465
60612
60637
60676
60865
60976
267*/11153
23203
42150
43473
60507
24133
44246
43474
42224
43478
60377
13449
24179

32383
43178
43294
60022
32386
56*/11103
31223

al cell receptors by HIV/
ortia/Self-assessment
re the key regulators/
West and Central Africa/
pe D infection in Brazil:
tinct genetic subtypes/
ovinces of South Africa/
f HIV infection in China/
han those with HIV-1 B/
epidemic in Shenzhen/
of HIV-1 in Switzerland/
DS dementia complex/
US-Europe-Australia/
g HIV-infected patients/
ort study in Switzerland/
aputo, Mozambique/
AIDS in southern Brazil/

SKeyword Abstr
of human blood-brain barrier e
modules: Evaluation and skill-building tool
Molecular mechanisms of HIV-1 nuclear i

act -
60794
44310
381*/11144

epidemiology of HIV-1 genetics
identification and clinical and im
characterization of human inmu
epidemiology of HIV-1 in KwaZ
epidemiology of HIV infection in
epidemiology of HIV-1 in Taiwa
epidemiology analysis of subty
epidemiology of HIV-1 in Switze
and biological characteristics of
and clinical evidence for Pneum
phylogeny of microsporidia incl
epidemiology of HIV-associate
epidemiology of HIV-1 in Maput
epidemiology of HIV/AIDS in so
determinants of HIV-1 tropism f

strocytes/The common molecular

de arrays/Quantitative analysis of mRNA expression o
ng infection/Infectious clones with the non-homologou
HIV strains/Biology and biology of HIV co-infection with
nhibitors/Importance of flexibility for the resistance of HI
of HIV-1 in Uganda/The epidemiology of HIV-1 in Ugan
pines, 1985-1997/The epidemiology of HIV-1 infection
ection in Australia/The epidemiology of long-term asy
HIV-1 through the use of adjuvants/Development of rati
f clinical predictors and epidemiologic assessment/An
pulation/Application of methods for detection and trans
a reservoir/Clinical and epidemiology of oropharyngeal
hy/Analysis of JC virus characteristics influencing the d
ns in Brazil/Preliminary evidence for a novel Mycobacte
by immunologycal and methods in seronegative wome
e/Evolutionary fate of a molecularly cloned simian-human immun
pic HIV-1 entry/A small molecule CXCR4 inhibitor that blocks T-c
80 and CD86 adhesion molecules on circulating T cells of HIV infe
nfection/Expression of responsible for lymphocyte acti
els of soluble adhesion during primary HIV-1 infection.
the over-expression of associated with B cell activatio
Expression of adhesion in recurrent aphthous ulcers in
nfect CD4+ T-cell lines, Molt 4 and SupT1/Study of co-receptors us
ations among women in Mombasa, Kenya/Primary HIV-1 infection
o train Aimag doctors in Mongolia in HIV/STD prevention/educatio
gladesh, Pakistan, and /HIV/STD prevention in high risk
esponse to HIV/AIDS in /Encouraging a multisectoral res
btypes using the HIV-1 MonitorTM with additional primers/Improve
oche Amplicor HIV-1 assay/Multi-center evaluation of
s/Ultra-sensitive HIV-1 Including ubiquitous primers to q
n of the HIV-1 Amplicor Monitor and NucliSens quantitative HIV-1
tion of Amplicor HIV-1 with added primer set with quantip
ment by Amplicor HIV-1: Analysis of within-lot and betwee
oche Amplicor HIV-1 assay using ultra sensitive sampl
f NucliSens and Roche assays for HIV-1 RNA quantitatio
BASAMPLICOR HIV-1 monitor test/Sensitivity, linear range and
s of the Amplicor HIV-1 test with new gag primers, and a p
" HIV EIA to qualify and anti-retroviral therapy trials in pati
Using an HIV register to the HIV epidemic at community le
ity and mortality data to the impact of the epidemic/Using
) patients, 1990-1996/ Monitoring HIV prevalence in Europe usin
newborns 1993-1997/ of HIV-seroprevalence in child
evel: Italy, 1990-1995/ the trend of HIV vertical trans
gh AIDS risk countries/ knowledge and behavior of tra
providers and families/ treatment adherence in pediat
rmation dissemination/ the AIDS pandemic (MAP) net
ra of new treatments/ the HIV/AIDS epidemic in Belg
ance system in Kenya: HIV levels and trends/The HIV
AIDS and HIV infection/ of the New Zealand epidemic

430*/11163
11192
12178
13125
13132
13148
13149
13207
21110
22177
31221
60413
60722
61003
11118
380*/11139
11161
11162
12277
431*/13109
13137
13348
21208
22137
22144
22215
22322
60412
60529
11219
11117
21125
21161
21173
22290
32250
11111
333*/12186
13480
43523
60110
41154
42143
60886
41127
41128
41134
41146
42162
41130
41145
42118
43465
43494
13180
13187
23296
23339
32438
33444
43450
43453
60603

with, and at-risk for HIV/ of service utilization and retention i
nt HIV/AIDS in Canada: of prevention education programs
d workplace: Cognitive models and learning models in a group of
oncepts, definitions and for community-based HIV preventi
erapy/Service delivery for treatment adherence to combin
obilization: Rethinking of HIV/AIDS prevention for gay an
ial of three intervention 'effectiveness in lowering STD/HI
ent of AIDS social work in the context of the complex resp
V - COmportamenti da Modificare Per La Incrementazione della
n by CCR5 antagonists/ Modulation of HIV-1 infection by CCR5 an
ng control region (LCR)/ of DNA viruses regulatory regi

onic liver disease/Drug monitoring of saquinavir during monother 12378
ppropriate quality of life tool - An issue for PHA empo 12458
ymous HIV prevalence in IDU, MSM, STD patients, an 13189
unity: A sentinel site for HIV genetic diversity in the Uni 13225
yte subsets pertinent to HIV-infected Chinese paediatr 13374
stics for evaluation and blood supply to hospitals/The 23262
ossible specimen for compliance and plasma levels 512*/32330
NA antiretroviral (ARV) /Self reported treatment adher 32379
e where no CD4 or RNA is available in Brazil/Antiretro 33167
f peer education and of the condom use by the sex 532*/33521
a, Per6/A new system and evaluation in a project of p 33595
d reporting systems for and evaluation of AIDS suppor 34323
nfection/lmmunological in HIV-infection/Immunologic 41126
s of HIV-RNA levels for HIV-1 positive individuals in co 42156